BRCA-mutated tumors exhibit a strong infiltration by CD8+ T cells that harbor a high PD-1 expression in ovarian cancer and some breast cancers such as HER2/neu+ tumors and TNBC (44, 47). Here, ERBB2 is linked to breast carcinoma.